72 filings
8-K
GTHX
G1 Therapeutics Inc
1 May 24
Results of Operations and Financial Condition
6:38am
8-K
GTHX
G1 Therapeutics Inc
22 Mar 24
Departure of Directors or Certain Officers
4:16pm
8-K
GTHX
G1 Therapeutics Inc
28 Feb 24
Results of Operations and Financial Condition
6:35am
8-K
GTHX
G1 Therapeutics Inc
12 Feb 24
Other Events
4:19pm
8-K
GTHX
G1 Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:30am
8-K
8vqc7vc
1 Nov 23
Results of Operations and Financial Condition
6:46am
8-K
z2njuac8 f7cw
21 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
a9h5nsk
2 Aug 23
Results of Operations and Financial Condition
6:50am
8-K
e1r63vfw4xkqcaypc
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
983sa94vesroideh
9 Jun 23
Entry into a Material Definitive Agreement
4:34pm
8-K
r806 jtjqwz34a
3 May 23
G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights
6:46am
8-K
amke2
10 Mar 23
Regulation FD Disclosure
4:18pm
8-K
bpogkic05i 2ex3aog
1 Mar 23
Results of Operations and Financial Condition
6:37am
8-K
3dhf67j3
13 Feb 23
Regulation FD Disclosure
6:30am
8-K
yx4 vn5cz9
9 Jan 23
Regulation FD Disclosure
6:39am
8-K
invn7gxp2dg
18 Nov 22
G1 Therapeutics Announces Pricing of Offering of Common Stock
8:00pm
8-K
bt5ls
2 Nov 22
G1 Therapeutics Provides Third Quarter 2022 Financial Results and Operational Highlights
6:45am
8-K
ijeaicy9ouvo40045l
3 Aug 22
G1 Therapeutics Provides Second Quarter 2022 Financial Results and Operational Highlights
6:35am
8-K
770ajbz
27 Jul 22
G1 Therapeutics Announces Addition of Norman E. Sharpless to Board of Directors
4:05pm
8-K
rbxil0koj0hha bhc
28 Jun 22
G1 Therapeutics Announces Addition of Jacks Lee to Board of Directors
4:58pm